BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 514940)

  • 1. Adverse reaction to disopyramide.
    Dibble JB; Webster NR
    Postgrad Med J; 1979 Sep; 55(646):570-2. PubMed ID: 514940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
    Romero-Ayala LC; SonĂ­ J
    Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiarrhythmic effect of intravenous disopyramide in an open study.
    Tonkin AM; Heddle WF; Bett JH; Kemp RJ; Donnelly GL; Nelson GI; Manolas E; Sloman JG
    Aust N Z J Med; 1982 Aug; 12(4):271-5. PubMed ID: 6958238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
    Meltzer RS; Robert EW; McMorrow M; Martin RP
    Am J Cardiol; 1978 Dec; 42(6):1049-53. PubMed ID: 727132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias.
    Stewart DE; Ikram H
    N Z Med J; 1984 Mar; 97(751):148-50. PubMed ID: 6584758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disopyramide-induced ventricular fibrillation.
    Nicholson WJ; Martin CE; Gracey JG; Knoch HR
    Am J Cardiol; 1979 May; 43(5):1053-5. PubMed ID: 433766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disopyramide.
    Koch-Weser J
    N Engl J Med; 1979 Apr; 300(17):957-62. PubMed ID: 431563
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of intravenous disopyramide in acute cardiac arrhythmias.
    De Backer M; Stoupel E; Kahn RJ
    Eur J Clin Pharmacol; 1981 Jan; 19(1):11-8. PubMed ID: 6161824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disopyramide induced atypical ventricular tachycardia.
    Chia BL
    Aust N Z J Med; 1980 Dec; 10(6):665-8. PubMed ID: 6938189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentially dangerous effect of disopyramide on atrioventricular conduction in a patient on digitalis.
    Lara M; Oakley GD; Rowbotham D
    Br Med J; 1980 Jul; 281(6234):198. PubMed ID: 7407521
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of multiple bolus loading of intravenous disopyramide.
    Simpson RJ; Foster JR; Benge C; Baker S; Gettes LS
    Am Heart J; 1983 Sep; 106(3):505-8. PubMed ID: 6881023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of intravenous disopyramide in the termination of supraventricular arrhythmias.
    Luoma PV; Kujala PA; Juustila HJ; Takkunen JT
    J Clin Pharmacol; 1978; 18(5-6):293-301. PubMed ID: 641217
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction.
    Jennings G; Jones MS; Besterman EM; Model DG; Turner PP; Kidner PH
    Lancet; 1976 Jan; 1(7950):51-4. PubMed ID: 54578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia.
    Griffith MJ; Linker NJ; Garratt CJ; Ward DE; Camm AJ
    Lancet; 1990 Sep; 336(8716):670-3. PubMed ID: 1975861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide.
    Commerford PJ; Beck W
    S Afr Med J; 1980 Sep; 58(11):447-8. PubMed ID: 7404173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collapse after oral administration of disopyramide.
    Manolas EG; Hunt D; Dowling JT; Luxton M; Vohra J
    Med J Aust; 1979 Jan; 1(1):20. PubMed ID: 763189
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of disopyramide by arrhythmia specialists after Cardiac Arrhythmia Suppression Trial: patient selection and initial outcome.
    Prystowsky EN; Waldo AL; Fisher JD
    Am Heart J; 1991 May; 121(5):1571-82. PubMed ID: 2017999
    [No Abstract]   [Full Text] [Related]  

  • 20. Disopyramide in myocardial infarction.
    Ross D; Vohra J; Sloman JG
    Lancet; 1978 Feb; 1(8059):330. PubMed ID: 75367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.